A risk of bias instrument for non-randomized studies of exposures: A users' guide to its application in the context of GRADE.

Bias Environmental Exposure / analysis Humans Random Allocation Research Design / standards Risk Assessment / standards
Environmental health GRADE Non-randomized studies ROBINS Risk of bias Study limitations

Journal

Environment international
ISSN: 1873-6750
Titre abrégé: Environ Int
Pays: Netherlands
ID NLM: 7807270

Informations de publication

Date de publication:
01 2019
Historique:
received: 14 09 2018
revised: 01 11 2018
accepted: 01 11 2018
pubmed: 27 11 2018
medline: 21 5 2019
entrez: 27 11 2018
Statut: ppublish

Résumé

The objective of this paper is to explain how to apply, interpret, and present the results of a new instrument to assess the risk of bias (RoB) in non-randomized studies (NRS) dealing with effects of environmental exposures on health outcomes. This instrument is modeled on the Risk Of Bias In Non-randomized Studies of Interventions (ROBINS-I) instrument. The RoB instrument for NRS of exposures assesses RoB along a standardized comparison to a randomized target experiment, instead of the study-design directed RoB approach. We provide specific guidance for the integral steps of developing a research question and target experiment, distinguishing issues of indirectness from RoB, making individual-study judgments, and performing and interpreting sensitivity analyses for RoB judgments across a body of evidence. Also, we present an approach for integrating the RoB assessments within the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework to assess the certainty of the evidence in the systematic review. Finally, we guide the reader through an overall assessment to support the rating of all domains that determine the certainty of a body of evidence using the GRADE approach.

Identifiants

DOI: 10.1016/j.envint.2018.11.004 PMID: 30473382 PMC: PMC8221004
pubmed: 30473382
pii: S0160-4120(18)32085-3
doi: 10.1016/j.envint.2018.11.004
pmc: PMC8221004
mid: NIHMS1710538
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

168-184

Subventions

Organisme : Intramural EPA
ID : EPA999999
Pays : United States

Informations de copyright

Copyright © 2018. Published by Elsevier Ltd.

Références

Environ Int. 2015 Oct;83:107-15
pubmed: 26115537
PLoS Med. 2009 Jul 21;6(7):e1000100
pubmed: 19621070
Environ Int. 2016 Jul-Aug;92-93:617-29
pubmed: 26857180
Environ Health. 2011 Apr 05;10 Suppl 1:S3
pubmed: 21489213
BMJ. 2016 Oct 12;355:i4919
pubmed: 27733354
Environ Res. 2011 Aug;111(6):825-30
pubmed: 21676388
Environ Health Perspect. 2014 Oct;122(10):1007-14
pubmed: 24968373
PLoS One. 2013 Jun 12;8(6):e65399
pubmed: 23776476
Br Med J. 1964 May 30;1(5395):1399-410
pubmed: 14135164
J Clin Epidemiol. 2011 Dec;64(12):1303-10
pubmed: 21802903
Environ Health. 2015 May 31;14:46
pubmed: 26026606
J Clin Epidemiol. 2019 Jul;111:105-114
pubmed: 29432858
J Clin Epidemiol. 2011 Apr;64(4):401-6
pubmed: 21208779
Environ Int. 2018 Dec;121(Pt 1):1027-1031
pubmed: 30166065
Environ Int. 2018 Nov;120:382-387
pubmed: 30125855
Environ Health Perspect. 2013 Apr;121(4):514-20
pubmed: 23416456
Environ Health. 2012 Oct 19;11:79
pubmed: 23083070
Am J Epidemiol. 2016 Apr 15;183(8):758-64
pubmed: 26994063
Environ Int. 2016 Jul-Aug;92-93:611-6
pubmed: 26827182
Am J Ind Med. 2007 Mar;50(3):199-207
pubmed: 17096363
Int J Epidemiol. 2005 Jun;34(3):680-7
pubmed: 15802377
J Clin Epidemiol. 2011 Dec;64(12):1311-6
pubmed: 21802902
J Chronic Dis. 1966 Jun;19(6):637-47
pubmed: 5966011
Br Med J. 1950 Sep 30;2(4682):739-48
pubmed: 14772469
Environ Health Perspect. 2016 Apr;124(4):498-506
pubmed: 26372668
Rev Environ Health. 2013;28(1):37-58
pubmed: 23612528
J Clin Epidemiol. 2011 Apr;64(4):407-15
pubmed: 21247734

Auteurs

Rebecca L Morgan (RL)

Department of Health Research Methods, Evidence, and Impact, McMaster University, Health Sciences Centre, Room 2C14, 1280 Main Street West, Hamilton, ON L8S 4K1, Canada. Electronic address: morganrl@mcmaster.ca.

Kristina A Thayer (KA)

Integrated Risk Information System (IRIS) Division, National Center for Environmental Assessment (NCEA), Office of Research and Development, US Environmental Protection Agency, Building B (Room 211i), Research Triangle Park, NC 27711, USA. Electronic address: thayer.kris@epa.gov.

Nancy Santesso (N)

Department of Health Research Methods, Evidence, and Impact, McMaster University, Health Sciences Centre, Room 2C14, 1280 Main Street West, Hamilton, ON L8S 4K1, Canada. Electronic address: santesna@mcmaster.ca.

Alison C Holloway (AC)

Department of Obstetrics and Gynecology, McMaster University, Health Sciences Centre, Room 3N52A, 1280 Main Street West, Hamilton, ON L8S 4K1, Canada. Electronic address: hollow@mcmaster.ca.

Robyn Blain (R)

ICF International Inc., 9300 Lee Highway, Fairfax, VA, USA. Electronic address: Robyn.Blain@icfi.com.

Sorina E Eftim (SE)

ICF International Inc., 9300 Lee Highway, Fairfax, VA, USA. Electronic address: Sorina.Eftim@icfi.com.

Alexandra E Goldstone (AE)

ICF International Inc., 9300 Lee Highway, Fairfax, VA, USA. Electronic address: Ali.Goldstone@icfi.com.

Pam Ross (P)

ICF International Inc., 9300 Lee Highway, Fairfax, VA, USA. Electronic address: Pam.Ross@icfi.com.

Mohammed Ansari (M)

School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, ON K1H 8M5, Canada. Electronic address: tosansari@gmail.com.

Elie A Akl (EA)

Department of Health Research Methods, Evidence, and Impact, McMaster University, Health Sciences Centre, Room 2C14, 1280 Main Street West, Hamilton, ON L8S 4K1, Canada; Department of Internal Medicine, Faculty of Health Sciences, American University of Beirut, P.O. Box: 11-0236, Riad-El-Solh Beirut 1107 2020, Lebanon. Electronic address: ea32@aub.edu.lb.

Tommaso Filippini (T)

Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Italy. Electronic address: tommaso.filippini@unimore.it.

Anna Hansell (A)

MRC-PHE Centre for Environment and Health, Imperial College London, St Mary's Campus, Praed St, Paddington, London W2 1PG, UK; Public Health Directorate, Imperial College Healthcare NHS Trust, St Mary's Hospital, Paddington, London, W2 1PG, UK; Centre for Environmental Health and Sustainability, University of Leicester, George Davies Building, University Road, Leicester LE1 7RH, UK. Electronic address: a.hansell@imperial.ac.uk.

Joerg J Meerpohl (JJ)

Institute for Evidence in Medicine (for Cochrane Germany Foundation), Medical Center - University of Freiburg, Breisacher Strasse 153, 79110 Freiburg, Germany. Electronic address: meerpohl@cochrane.de.

Reem A Mustafa (RA)

Department of Health Research Methods, Evidence, and Impact, McMaster University, Health Sciences Centre, Room 2C14, 1280 Main Street West, Hamilton, ON L8S 4K1, Canada; Division of Nephrology and Hypertension, Department of Medicine, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS 66160, USA.

Jos Verbeek (J)

Finnish Institute of Occupational Health, Cochrane Work, Neulaniementie 4, 70701 Kuopio, Finland. Electronic address: Jos.Verbeek@ttl.fi.

Marco Vinceti (M)

Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Italy; Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA. Electronic address: mvinceti@bu.edu.

Paul Whaley (P)

Lancaster Environment Centre, Lancaster University, Lancaster LA1 4YQ, UK. Electronic address: p.whaley@lancaster.ac.uk.

Holger J Schünemann (HJ)

Department of Health Research Methods, Evidence, and Impact, McMaster University, Health Sciences Centre, Room 2C14, 1280 Main Street West, Hamilton, ON L8S 4K1, Canada; Department of Medicine, McMaster University, Health Sciences Centre, Room 2C14, 1280 Main Street West, Hamilton, ON L8S 4K1, Canada. Electronic address: schuneh@mcmaster.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Environnement et santé publique › Santé publique › Facteurs épidémiologiques › Biais (épidémiologie) › A risk of bias instrument for non-randomized...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Pollution de l'environnement › Exposition environnementale › A risk of bias instrument for non-randomized...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › A risk of bias instrument for non-randomized...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Méthodologie en recherche épidémiologique › Répartition aléatoire › A risk of bias instrument for non-randomized...
questionsmedicales.fr › Disciplines des sciences naturelles › Science › Recherche › Plan de recherche › A risk of bias instrument for non-randomized...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Appréciation des risques › A risk of bias instrument for non-randomized...